Business Description
Compumedics Ltd
ISIN : AU000000CMP2
Total Employee Number:
135Description
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.63 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.82 | |||||
Beneish M-Score | -3.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.1 | |||||
3-Year Book Growth Rate | 2.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 266.18 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.16 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.54 | |||||
9-Day RSI | 51.59 | |||||
14-Day RSI | 52.66 | |||||
3-1 Month Momentum % | -11.76 | |||||
6-1 Month Momentum % | -26.23 | |||||
12-1 Month Momentum % | -25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 0.74 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 174.23 | |||||
Days Sales Outstanding | 87.78 | |||||
Days Payable | 106.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | -5.07 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.41 | |||||
Operating Margin % | -0.68 | |||||
Net Margin % | 0.36 | |||||
EBITDA Margin % | 8.91 | |||||
FCF Margin % | 4.48 | |||||
OCF Margin % | 10.96 | |||||
ROE % | 0.95 | |||||
ROA % | 0.39 | |||||
ROIC % | -0.13 | |||||
3-Year ROIIC % | 44.63 | |||||
ROC (Joel Greenblatt) % | 22.11 | |||||
ROCE % | 12.46 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 250 | |||||
Forward PE Ratio | 6.76 | |||||
PE Ratio without NRI | 250 | |||||
PS Ratio | 0.83 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 12.5 | |||||
Price-to-Free-Cash-Flow | 19.23 | |||||
Price-to-Operating-Cash-Flow | 7.58 | |||||
EV-to-EBIT | 18.25 | |||||
EV-to-EBITDA | 10.78 | |||||
EV-to-Revenue | 0.96 | |||||
EV-to-FCF | 21.43 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 12.5 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Graham-Number | 12.5 | |||||
Earnings Yield (Greenblatt) % | 5.48 | |||||
FCF Yield % | 5.41 | |||||
Forward Rate of Return (Yacktman) % | 5.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Compumedics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 60.254 | ||
| EPS (TTM) (A$) | 0.001 | ||
| Beta | 1.3403 | ||
| 3-Year Sharpe Ratio | 0.33 | ||
| 3-Year Sortino Ratio | 0.76 | ||
| Volatility % | 45.69 | ||
| 14-Day RSI | 52.66 | ||
| 14-Day ATR (A$) | 0.014912 | ||
| 20-Day SMA (A$) | 0.2435 | ||
| 12-1 Month Momentum % | -25 | ||
| 52-Week Range (A$) | 0.215 - 0.45 | ||
| Shares Outstanding (Mil) | 199.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Compumedics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Compumedics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Compumedics Ltd Frequently Asked Questions
What is Compumedics Ltd(ASX:CMP)'s stock price today?
The current price of ASX:CMP is A$0.25. The 52 week high of ASX:CMP is A$0.45 and 52 week low is A$0.22.
When is next earnings date of Compumedics Ltd(ASX:CMP)?
The next earnings date of Compumedics Ltd(ASX:CMP) is .
Does Compumedics Ltd(ASX:CMP) pay dividends? If so, how much?
Compumedics Ltd(ASX:CMP) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Compumedics Achieves World-First Adult and Child Optimized Recordings from a Single MEG System | 2025-05-14 |
Articles on Compumedics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers